RedHill Biopharma added to NASDAQ Biotechnology Index

 

• The specialty biopharmaceutical company, RedHill Biopharma (NASDAQ:RDHL) announces, the company will become a part of the NASDAQ Biotechnology Index with effect from December 21, 2020.
• Ahead of the demand from the funds tracking the index, the stock is trading +7.7% higher in the pre-market trading.
• The company primarily focused on gastrointestinal and infectious diseases has returned +33.6% in value for the year so far, compared to the +23.8% rise in the iShares NASDAQ Biotechnology Index Fund, which tracks the index.
• https://seekingalpha.com/news/3644029-redhill-biopharma-added-to-nasdaq-biotechnology-index